is tirzepatide still on shortage list FDA says over after taking a second look The FDA has proposed to
Description
Tirzepatide primarily affects insulin and incretin hormones (GLP-1 and GIP)
To view or add a comment, sign in GLP1s are powerful toolsbut theyre not magic
Its uses include treating tract infections and even serious ailments such as Lyme disease highlighting its versatility
FUNDING INFORMATION Not applicable
